- Home
- ORGO vs EVTL Comparison
ORGO vs EVTL Comparison
Compare ORGO & EVTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORGO | EVTL |
|---|---|---|
| Founded | 1985 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | 454 |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 348.6M | 338.7M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | ORGO | EVTL |
|---|---|---|
| Price | $2.47 | $2.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $8.50 | ★ $12.70 |
| AVG Volume (30 Days) | 1.3M | ★ 2.9M |
| Earning Date | 05-07-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1600.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $564,169,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $26.27 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.04 | N/A |
| 52 Week Low | $2.04 | $1.90 |
| 52 Week High | $7.08 | $7.60 |
Technical Indicators
Market Signals| Indicator | ORGO | EVTL |
|---|---|---|
| Relative Strength Index (RSI) | 49.77 | 43.64 |
| Support Level | $2.21 | $2.20 |
| Resistance Level | $2.63 | $2.85 |
| Average True Range (ATR) | 0.21 | 0.21 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 59.73 | 35.40 |
Price Performance
Historical ComparisonAbout ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About EVTL Vertical Aerospace Ltd.
Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.